Back Login for AI Analysis

    CLRB (STOCKS)

    Cellectar Biosciences INC NEW

    $2.500000
    -0.100000 (-3.85%)
    Prev close: $2.600000
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Pharmaceuticals: Major
    CEO
    James V. Caruso
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $19.82M
    Employees
    11
    P/E (TTM)
    -0.34
    P/B (TTM)
    3.92
    Dividend Yield
    —
    Technical Indicators
    SMA 10
    —
    SMA 20
    —
    SMA 50
    —
    EMA 9
    —
    EMA 21
    —
    RSI
    —
    MACD State
    —
    Recent News

    No recent news found for this ticker.

    Financial Statements
    TTM (Mar 2026)
    Revenues $0.00
    Costs And Expenses $22.37M
    Nonoperating Income/Loss $1.53M
    Research and Development $11.08M
    Operating Income/Loss -$22.37M
    Income/Loss From Continuing Operations After Tax -$13.99M
    Income/Loss From Continuing Operations Before Tax -$20.59M
    Net Income/Loss -$20.84M
    Net Income/Loss Attributable To Noncontrolling Interest $0.00
    Net Income/Loss Attributable To Parent -$20.84M
    Net Income/Loss Available To Common Stockholders, Basic -$20.84M
    Participating Securities, Distributed And Undistributed Earnings/Loss, Basic $0.00
    Preferred Stock Dividends And Other Adjustments $0.00
    Basic Earnings Per Share -$6.66
    Diluted Earnings Per Share -$6.66
    Basic Average Shares 9,511,051
    Diluted Average Shares 9,511,051
    Assets $11.12M
    Current Assets $9.27M
    Noncurrent Assets $1.85M
    Fixed Assets $339.70K
    Other Non-current Assets $1.51M
    Liabilities $6.40M
    Current Liabilities $4.87M
    Noncurrent Liabilities $1.53M
    Equity $3.34M
    Equity Attributable To Noncontrolling Interest $0.00
    Equity Attributable To Parent $3.34M
    Liabilities And Equity $11.12M
    Net Cash Flow From Operating Activities -$18.58M
    Net Cash Flow From Operating Activities, Continuing -$18.58M
    Net Cash Flow -$709.14K
    Net Cash Flow, Continuing -$709.14K
    Comprehensive Income/Loss -$20.84M
    Comprehensive Income/Loss Attributable To Noncontrolling Interest $0.00
    Comprehensive Income/Loss Attributable To Parent -$20.84M
    Other Comprehensive Income/Loss $0.00